Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000126733 | SCV000170245 | benign | not specified | 2014-05-16 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Genetic Services Laboratory, |
RCV000126733 | SCV000193648 | benign | not specified | 2015-08-10 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000576205 | SCV000676973 | benign | Intellectual disability, autosomal dominant 20 | 2024-12-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002362766 | SCV002658945 | likely benign | Inborn genetic diseases | 2018-12-29 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV005243126 | SCV005892955 | likely benign | not provided | 2024-12-01 | criteria provided, single submitter | clinical testing | MEF2C: BP4, BP7, BS1 |
Prevention |
RCV004532520 | SCV004754347 | benign | MEF2C-related disorder | 2019-10-28 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |